BIOTON Company Description

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles.

BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

BIOTON S.A.

Country	Poland
Founded	1989
Industry	Biotechnology
Sector	Healthcare
Employees	364
CEO	Jeremy Launders

Contact Details

Address: ul. Poznanska 12 Ozarów Mazowiecki, 05-850 Poland
Phone	48 22 721 4000
Website	bioton.pl

Stock Details

Ticker Symbol	BIO
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
ISIN Number	PLBIOTN00029
SIC Code	2834

Key Executives

Name	Position
Mateusz Patryk Kosecki	Head of Biolek Business Unit and Chief Executive Officer of Biolek Sp. Z O.O.
Artur Mroz-Goncalves	Chief Executive Officer and Sales and Marketing Director at Bioton Marketing Agency (BMA)
Jeremy Launders	Chief Executive Officer and President of the Management Board
Adam Tomasz Polonek	Member of Management Board
Anna Grabowska	Senior Finance Manager
Michal Deptuch	Operations Director
Renata Prokopczyk	Chief Accountant
Dariusz Gurtowski	Director of Science and Technology
Kamila Musnicka	Director of Legal Department
Ewelina Romanska	Director of Human Resources and Communication